Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Duckworth

Neurological Surgery Houston, TX Medical Doctor

NPI 1003038043 CMS profile 272188

1709 Dryden Rd, Suite 750 - Department Of Neurosurgery, Houston, TX 77030

Open in the dashboard

General payments

$31,881

115 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edward Duckworth of Houston, TX is reported in the CMS Open Payments database as having received $31,881 across 115 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $687 19
2024 General $840 11
2023 General $8,778 14
2022 General $9,802 32
2021 General $7,004 14
2020 General $200 8
2019 General $4,570 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Duckworth
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Edward Duckworth were reported at $687. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Edward Duckworth Neurological Surgery median Middle half National median
2019 $4,570 $582 $138–$3,006 $163
2020 $200 $294 $76–$2,174 $114
2021 $7,004 $387 $105–$2,432 $132
2022 $9,802 $542 $139–$2,989 $149
2023 $8,778 $534 $145–$2,697 $160
2024 $840 $574 $155–$3,046 $164
2025 $687 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. BK Medical Holding Company Inc. $20,795 4 payments
  2. Brainlab, Inc. $3,045 9 payments
  3. Stryker Corporation $2,089 26 payments
  4. MicroVention, Inc. $2,058 13 payments
  5. GT Medical Technologies, Inc $1,103 6 payments
  6. DePuy Synthes Sales Inc. $529 7 payments
  7. Medtronic, Inc. $479 14 payments
  8. Siemens Medical Solutions USA, Inc. $440 3 payments
  9. Penumbra, Inc. $302 6 payments
  10. Medtronic USA, Inc. $253 5 payments
  11. Other $789 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,530 3 payments
  2. Consulting Fee $6,700 2 payments
  3. Food and Beverage $5,114 98 payments
  4. Travel and Lodging $3,788 11 payments
  5. Honoraria $750 1 payment
Products named General payments · program years 2019–2025
  1. bk3000, bk3500 & bk5000 Ultrasound System $14,595 3 payments
  2. WEB $1,735 7 payments
  3. GammaTile $1,002 5 payments
  4. N/A $831 7 payments
  5. Image Guided Surgical Device $569 3 payments
  6. VISUALASE $271 2 payments
  7. WEB ANEURYSM EMBOLIZATION SYSTEM $259 3 payments
  8. DURAMATRIX $238 4 payments
  9. CORE $227 4 payments
  10. CorPath Imaging System $203 1 payment
  11. Other $3,841 95 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$103,301

Medicare's payments for the services billed

Medicare patients

90

Average age 72

Services billed

263

51 women, 39 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 50%
Depression 37%
Cancer 27%
Osteoporosis 26%
Diabetes 20%
Ischemic heart disease 18%
COPD 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

115 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record